Ultragenyx Pharmaceutical Inc. Profile Avatar - Palmy Investing

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internat…
Biotechnology
US, Novato [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of Ultragenyx Pharmaceutical Inc.

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
-100.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
- -% Yield
0.00% Payout Ratio
End of RARE's Analysis
CIK: 1515673 CUSIP: 90400D108 ISIN: US90400D1081 LEI: - UEI: -
Secondary Listings
RARE has no secondary listings inside our databases.